OUE Healthcare Limited (SGX:5WA)
Singapore · Delayed Price · Currency is SGD 0.0350
0.00 (0.00%)
At close: Jul 28, 2026
OUE Healthcare Financials Overview
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 152.39 | 152.39 | 150.28 | 159.32 | 119.8 | 19.67 |
Revenue Growth | 1.26% | 1.41% | -5.67% | 32.99% | 509.18% | -1.58% |
Gross Profit Gross Profit Growth | 114.39 | 114.39 | 114.17 | 121.73 | 101.61 | 14.57 |
Operating Income Operating Income Growth | 80.07 | 80.07 | 85.75 | 93.12 | 78.63 | 3.39 |
Net Income Net Income Growth | -16.87 | -16.87 | -6 | 8.05 | 4.39 | 111.38 |
Earnings Per Share EPS Growth | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.02 |
EPS Growth | - | - | - | 83.33% | -96.45% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Elimination of Inter-Segment Elimination of Inter-Segment Growth | -0.66 | -0.66 | -0.93 | -0.45 | -1.1 | -1.49 |
Healthcare Operations Healthcare Operations Growth | 51.86 | 51.86 | 48.07 | 50.75 | 21.73 | 2.95 |
Healthcare Assets Healthcare Assets Growth | 100.53 | 100.53 | 102.21 | 108.57 | 98.07 | 16.71 |
Others Others Growth | 0.66 | 0.66 | 0.93 | 0.45 | 1.1 | 1.49 |
Total Total Growth | 152.39 | 152.39 | 150.28 | 159.32 | 119.8 | 19.67 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 84.77 | 84.77 | 70.65 | 60.59 | 67.64 | 44.13 |
Total Debt Total Debt Growth | 552.66 | 552.66 | 550.34 | 560.82 | 512.82 | 188.44 |
Net Cash (Debt) Net Cash Growth | -467.89 | -467.89 | -479.7 | -500.22 | -445.18 | -144.3 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.11 | -0.11 | -0.11 | -0.07 | -0.06 | -0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 56.41 | 56.41 | 60.71 | 65.52 | 51.62 | 4.09 |
Capital Expenditures CapEx Growth | -1.61 | -1.61 | -0.61 | -0.48 | -0.61 | -0.95 |
Free Cash Flow Free Cash Flow Growth | 54.8 | 54.8 | 60.11 | 65.05 | 51.01 | 3.14 |
Free Cash Flow Growth | -0.76% | -8.83% | -7.59% | 27.52% | 1526.04% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 75.06% | 75.06% | 75.97% | 76.41% | 84.82% | 74.11% |
Operating Margin | 52.54% | 52.54% | 57.06% | 58.45% | 65.64% | 17.23% |
Pretax Margin | 15.39% | 15.39% | 27.01% | 46.77% | 41.52% | 550.61% |
Profit Margin | -11.07% | -11.07% | -4.00% | 5.05% | 3.67% | 566.38% |
FCF Margin | 35.96% | 35.96% | 40.00% | 40.83% | 42.58% | 15.95% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 16.01 | 29.34 | 1.56 |
P/FCF Ratio | 2.84 | 2.27 | 2.14 | 1.98 | 2.53 | 55.24 |
PS Ratio | 1.02 | 0.82 | 0.86 | 0.81 | 1.08 | 8.81 |